Maa: Australia
Kieli: englanti
Lähde: Department of Health (Therapeutic Goods Administration)
tamsulosin hydrochloride, Quantity: 400 microgram
Sandoz Pty Ltd
Tablet, modified release
Excipient Ingredients: quinoline yellow; purified talc; polyethylene oxide; cochineal; microcrystalline cellulose; magnesium stearate; hyprolose; butylated hydroxytoluene; macrogol 400; titanium dioxide; iron oxide black; hypromellose; colloidal anhydrous silica
Oral
30, 10
(S4) Prescription Only Medicine
For the relief of lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH).
Visual Identification: Brown, round, biconvex film-coated tablets with debossing '0.4' on one side and 'SZ' on the other side; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert
Registered
2022-09-19
BTC Tamsulosin SR® 1 BTC TAMSULOSIN® SR CONSUMER MEDICINE INFORMATION (CMI) SUMMARY The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. 1. WHY AM I USING BTC TAMSULOSIN SR? BTC Tamsulosin SR contains the active ingredient tamsulosin and belongs to a group of medicines called alpha-blockers. BTC Tamsulosin SR is used in men who have a medical condition called benign prostatic hyperplasia (also known at BPH). In BPH the prostate gland is bigger than normal. BPH is NOT prostate cancer. For more information, see Section 1. Why am I using BTC Tamsulosin SR? in the full CMI. 2. WHAT SHOULD I KNOW BEFORE I USE BTC TAMSULOSIN SR? BTC Tamsulosin SR is for use by MEN only. If you are a woman or a child, do not take BTC Tamsulosin SR. If you are not sure whether you should start taking BTC Tamsulosin SR, you should contact your doctor. There are a number of circumstances in which a person should not use this medicine or may need to use caution. It is important to understand if these apply to your before taking BTC Tamsulosin SR. Do not use BTC Tamsulosin SR if you have ever had an allergic reaction to tamsulosin or any of the ingredients listed at the end of the CMI. For more information, see Section 2. What should I know before I use BTC Tamsulosin SR? in the full CMI. 3. WHAT IF I AM TAKING OTHER MEDICINES? Some medicines may interfere with BTC Tamsulosin SR and affect how it works. A list of these medicines is in Section 3. What if I am taking other medicines? in the full CMI. 4. HOW DO I USE BTC TAMSULOSIN SR? • The usual dose is one tablet a day. • The tablet should be swallowed whole, preferably with a glass of water. Do not crunch, bite or chew the tablet. More instructions can be found in Section 4. How do I use BTC Tamsulosin SR? in the full CMI. 5. WHAT SHOULD I KNOW WHILE USING BTC TAMSULOSIN SR? THINGS YOU SHOULD DO • Remind any doctor, dentist or pharmacist you visit that you are using BTC Tamsulosin SR or if you are about to Lue koko asiakirja
220919-BTC Tamsulosin SR-pi Page 1 of 13 AUSTRALIAN PRODUCT INFORMATION BTC TAMSULOSIN ® SR (TAMSULOSIN HYDROCHLORIDE) MODIFIED RELEASED TABLETS 1 NAME OF THE MEDICINE Tamsulosin hydrochloride 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each BTC Tamsulosin SR 400 µg modified release tablet contains 400 µg tamsulosin hydrochloride. For the full list of excipients, see Section 6.1 List of excipients. 3 PHARMACEUTICAL FORM BTC Tamsulosin SR 400 µg are brown, round, biconvex film-coated tablets with debossing ‘0.4’ on one side and ‘SZ’ on the other side. 4 CLINICAL PARTICULARS 4.1 T HERAPEUTIC INDICATIONS For the relief of lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). 4.2 D OSE AND METHOD OF ADMINISTRATION DOSAGE One tablet daily. METHOD OF ADMINISTRATION The tablet must be swallowed whole and not be broken, crunched or chewed, as this compromises the prolonged release properties of the tablet for the active ingredient. BTC Tamsulosin SR can be taken on an empty stomach, or before, with or after food. 4.3 C ONTRAINDICATIONS • Hypersensitivity, including drug-induced angioedema to tamsulosin hydrochloride or any other component of the product. • A history of orthostatic hypotension. • SEVERE hepatic impairment (Child-Pugh scores > 9). • SEVERE renal impairment with creatinine clearance of less than 10 mL/min. • Concurrent use of another α 1 -adrenoceptor inhibitor. 4.4 S PECIAL WARNINGS AND PRECAUTIONS FOR USE SYNCOPE AND POSTURAL HYPOTENSION Patients beginning treatment with BTC Tamsulosin SR tablets should be cautioned to avoid situations where injury could result should syncope occur. Postural hypotension can occur during treatment with BTC Tamsulosin SR, but rarely results in syncope. However, the patient 220919-BTC Tamsulosin SR-pi Page 2 of 13 should be warned of this possibility and advised to sit or lie down if symptoms of hypotension should occur. EXCLUSION OF PROSTATIC CARCINOMA AND OTHER UROLOGICAL CONDITIONS Carcinoma of the prostate and other Lue koko asiakirja